Expression of multidrug resistance protein in metastatic colorectal carcinomas
โ Scribed by Atsushi Nanashima; Hiroyuki Yamaguchi; Seiji Matsuo; Yorihisa Sumida; Takashi Tsuji; Terumitsu Sawai; Toru Yasutake; Tohru Nakagoe; Hiroyoshi Ayabe
- Book ID
- 106181203
- Publisher
- Springer Japan
- Year
- 1999
- Tongue
- English
- Weight
- 325 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
BACKGROUND. Multidrug resistance protein (MRP) is a membrane
## BACKGROUND. We examined the relationship between the expression of a multidrug resistance-associated protein (MRP) and the biologic factors regarding invasion and metastasis of human gastric cancer. ## METHODS. In 75 patients with gastric cancer, the expression of MRP was immunohistochemical
The intrinsic or acquired resistance of urothelial cancer to chemotherapy is one major obstacle to successful treatment. Generally, the expression level of P-glycoprotein in urothelial cancer is low, so we accordingly investigated the expression of multidrug resistance-associated protein (MRP). We e
MRP has been identified as another multidrug-resistance (MDR) gene and may be involved in an alternative MDR mechanism in some solid tumors. We investigated the expres- sion of M R P mRNA in multidrug-resistant KB sublines (KB-8-5, KB-CZ, C -W and C A I to), human non-small-cell lung carcinomas (NSC
โค-catenin plays a fundamental role in the regulation of the E-cadherin-catenin cell adhesion complex. It also functions in growth signalling events, independently of the cadherincatenin complex, and these signalling pathways are disturbed in colorectal cancer. Mutations in either the APC or โค-cateni